Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. ultraeasy

UltraEASY

Computer Aided Multispectral Ulstrasound Diagnostic Device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 UltraEASY project word cloud

Explore the words cloud of the UltraEASY project. It provides you a very rough idea of what is the project "UltraEASY" about.

monitoring    someone    ultraeasy    events    36    evaluation    underlying    europeans    stroke    specialist    flexibility    feedback    therewith    realization    frame    diagnose    molecular    neuropathologies    economic    2006    risk    interpretable    mobile    time    amounts    ambulances    final    carriers    waves    tissue    trade    stands    patients    first    insurance    multiple    medtech    diagnosing    things    ag    killing    acquisition    global    acute    rescue    immense    modern    clinics    groups    vitals    examination    regard    therapeutic    diagnostic    diagnosis    patient    multispectral    basic    thanks    innovation    family    beginning    invasive    conclude    seconds    helicopters    precise    initial    conduct    frequencies    eur    strategies    every    ing    sonovum    small    units    practices    damage    feasibility    harmful    version    camud    mobility    continuous    clinical    daily    preventatively    wake    market    ultrasound    markets    suited    computer    incidents    billion    suffers    acoustics    vehicles    diagnostics    fast    emergency    validation    acceptance    aided    physicians    brain    health   

Project "UltraEASY" data sheet

The following table provides information about the project.

Coordinator		 SONOVUM AG 

Organization address
address: PERLICKSTRASSE 5
city: LEIPZIG
postcode: 4103
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Project website http://www.sonovum.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SONOVUM AG DE (LEIPZIG) coordinator 50˙000.00

Map

 Project objective

Every 40 seconds, someone in Europe suffers from a stroke killing 1,000 Europeans daily. The resulting economic damage is immense. In the 2006 wake-up-study funded by the EU the economic damage in Europe amounts to 36 billion EUR per year. The objective of this project is the clinical validation of SoNovum AG’s UltraEASY™ II Brain Vitals Monitoring System and the underlying CAMUD technology for diagnosing and monitoring neuropathologies in acute events and at-risk patient groups. CAMUD stands for “Computer Aided Multispectral Ultrasound Diagnostics” and is a novel diagnostic method based on molecular acoustics. It measures the feedback of ultrasound waves on multiple frequencies, which is interpretable for the first time thanks to modern computer technology. The technology enables, among other things, a fast, very precise and non-invasive diagnosis of the brain tissue in the beginning of the therapeutic time frame as well as further, continuous monitoring. Therewith physicians will be able to diagnose acute events more quickly and preventatively at-risk patient groups, even before harmful incidents occur. Initial target market groups for UltraEASY II include the stroke units in clinics as well as family and specialist's practices in Europe with regard to global markets as well. Because of high mobility, flexibility and the small acquisition costs, it is well suited as basic equipment for practices as well as, in its mobile version, for helicopters, rescue vehicles and ambulances of clinics and emergency organizations. The objectives of this Feasibility Study are the examination of the market acceptance towards UltraEASY II, addressing clinics and physicians as well as involving patients, patient organizations and health insurance carriers, in order to conduct the risk evaluation for the final realization of the CAMUD technology in the MedTech sector and conclude the development of final innovation strategies for Phase 2.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTRAEASY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTRAEASY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More